ライフサイエンスコーパス: retrospectively

1 ent disease after chemotherapy were analyzed retrospectively.

2 Agreement analysis was performed retrospectively.

3 ata were recorded prospectively and analyzed retrospectively.

4 ment of LOP between 2010-2014 were evaluated retrospectively.

5 uded between 2005 and 2013 and were analyzed retrospectively.

6 inic (MDBCC) from 2008 to 2013 were reviewed retrospectively.

7 Clinical and laboratory data were collected retrospectively.

8 ical centers from 2011 to 2016 were enrolled retrospectively.

9 rom January 2011 to April 2013 were reviewed retrospectively.

10 cal and echocardiographic data were analyzed retrospectively.

11 d review, and testing of available specimens retrospectively.

12 n November 1992 and March 2014 were analyzed retrospectively.

13 age at inclusion of 10 months) were analyzed retrospectively; 22 patients have become tolerant (media

14 kes, we assessed erectile function after and retrospectively 3 months prior to the stroke using score

15 efined as at least 1 HF sign or symptom, was retrospectively adjudicated for 289 patients meeting ARV

16 All children had VL assayed retrospectively after a median of 4 years on ART; those

17 MATERIAL/We retrospectively analysed 214 patients who underwent para

18 We retrospectively analysed a cohort of consecutive patient

19 We retrospectively analysed data from a Zika virus outbreak

20 We then retrospectively analysed follow-up data from prospective

21 We retrospectively analysed genotypic and phenotypic data (

22 p 1: pre-endoscopy serology availability was retrospectively analysed in a multicentre cohort of 934

23 We retrospectively analysed patients from 20 studies within

24 To retrospectively analyze the effect of plasma exchange (P

25 the PET/CT examinations of 148 patients were retrospectively analyzed (LC: 327 LNs of 40 patients; MM

26 The authors retrospectively analyzed 1,940 consecutive HCM patients

27 We retrospectively analyzed 352 patients with RAI-avid meta

28 Of 500 episodes of bacteremia, we retrospectively analyzed 383 (77%) that had at least 1 F

29 We retrospectively analyzed 48 345 culture-confirmed NTS in

30 We retrospectively analyzed 58 cases: 49 had SEEG and 39 co

31 thods To estimate the incidence of LR-HL, we retrospectively analyzed 6,840 patients with cHL include

32 METHODS AND We retrospectively analyzed 78 patients undergoing surgical

33 We retrospectively analyzed 783 AL patients newly diagnosed

34 We retrospectively analyzed a cohort of 109 subjects treate

35 eneous population and treatment settings, we retrospectively analyzed a cohort of 2093 patients 18 ye

36 We retrospectively analyzed all HCT recipients between 2004

37 We retrospectively analyzed all noncancer patients admitted

38 ter in Hong Kong between 1999 and 2014, were retrospectively analyzed and compared.

39 Outcome measures were retrospectively analyzed by intention to treat.

40 emiannual progress tests during 5 years were retrospectively analyzed by using a nonlinear mixed-effe

41 We retrospectively analyzed clinical data and US examinatio

42 ly proposed clinicoradiological criteria and retrospectively analyzed clinical medical records and ma

43 lphenidate-induced dopamine (DA) release, we retrospectively analyzed D2R availability measures of 8

44 Here, we retrospectively analyzed data from 1253 CSU patients fro

45 nsent and with HIPAA compliance, the authors retrospectively analyzed DTI images of the knee in 151 c

46 We retrospectively analyzed electronic medical records of p

47 DCE-MRIs were retrospectively analyzed for 51 cancer cases and 51 cont

48 Clinical data were retrospectively analyzed for viral kinetics and for rena

49 Data were prospectively collected and retrospectively analyzed from the British Cardiovascular

50 x ligation-dependent probe amplification and retrospectively analyzed medical charts for 115 patients

51 We retrospectively analyzed patients at the Keelung Chung G

52 We retrospectively analyzed patients with PPI-related DHR f

53 (ABP) and intracranial pressure (ICP), were retrospectively analyzed to calculate the traditional PR

54 -2011), conducted in the United States, were retrospectively analyzed to derive statistically optimiz

55 rmal findings on stress perfusion SPECT were retrospectively analyzed to provide the reference limits

56 entilator-free days and alive at day 28 were retrospectively analyzed using regression models in diff

57 Here, we retrospectively analyzed, with up to 18 years follow-up,

58 between January 2009 and December 2009 were retrospectively analyzed.

59 om January 1, 2010, to January 1, 2016, were retrospectively analyzed.

60 ET/CT for noncardiovascular indications were retrospectively analyzed.

61 ge Liver Disease exception was approved were retrospectively analyzed.

62 ta from prospectively included patients were retrospectively analyzed.

63 2015 from 4 large academic institutions were retrospectively analyzed.

64 ers from 45 families; cardiac disorders were retrospectively analyzed.

65 went prostatectomy and preoperative PET were retrospectively analyzed.

66 ne metastases during (223)Ra-dichloride were retrospectively analyzed.

67 Imaging Network Pennsylvania 4006 trial was retrospectively analyzed.

68 in one breast (BI-RADS 1), whose cases were retrospectively analyzed.

69 ges of patients with NTM otomastoiditis were retrospectively analyzed.

70 /groups from 20 countries were collected and retrospectively analyzed.

71 n of 1992 patients with BAV (71.5% men) were retrospectively analyzed.

72 mammograms were available for analysis were retrospectively analyzed.

73 who underwent LT between 2008 and 2014 were retrospectively analyzed.

74 TIPS from January 2000 to January 2010 were retrospectively analyzed.

75 nd multiple sclerosis clinical services were retrospectively and anonymously scored on a set of 29 pr

76 or blunt trauma over 36 months were reviewed retrospectively and chest trauma CT studies were evaluat

77 ral agents while awaiting LT were identified retrospectively and followed up prospectively.

78 noninterventional extension study to collect retrospectively and prospectively annual follow-up data

79 Using both retrospectively and prospectively collected specimens fr

80 We retrospectively and prospectively investigated 27 matern

81 sphamide (BuCy) conditioning (data collected retrospectively) and 92 receiving busulfan/fludarabine (

82 We have retrospectively applied large-scale proteomics to blood

83 ETHODS AND The original prediction model was retrospectively applied to 3491 consecutive patients und

84 At a freestanding pediatric hospital, we retrospectively assessed anti-infective cost using pharm

85 disease stratified by sex and phenotype, we retrospectively assessed event-free survival from birth

86 Activity kinetics were retrospectively assessed from planar images in 29 patien

87 maging features with late adverse events was retrospectively assessed in 83 patients with acute uncom

88 rdiomyopathy patients with heart failure, we retrospectively assessed right heart catheterization dat

89 We retrospectively assessed the efficacy and toxicity of ni

90 tion with broad sorting gates, allowed us to retrospectively assign cells to 12 commonly sorted HSPC

91 f severe aortic stenosis has classically and retrospectively been based on the natural history of pat

92 ening (Group II, 344 fetuses), were analyzed retrospectively between 2007 and 2013.

93 The 4D PET datasets were retrospectively binned into 4 motion amplitude frames co

94 hing 3-dimensional MR data were acquired and retrospectively binned into multiple respiratory and car

95 eated P. falciparum infections were detected retrospectively by PCR (n = 55), and (3) uninfected chil

96 a putative case of congenital Zika syndrome retrospectively by unusually high ZIKV-specific antibody

97 Baseline SYNTAX scores were retrospectively calculated for BARI-2D patients without

98 We retrospectively classified patients according to PCR res

99 he PAM50 classifier was used to subtype 1567 retrospectively collected (median follow-up, 10 years) a

100 We retrospectively collected 497 meningiomas along with 309

101 Mammographic and MR imaging features were retrospectively collected according to the BI-RADS lexic

102 The St Jude Lifetime Cohort Study (SJLIFE) retrospectively collected data on CHCs in all patients t

103 anuary 1, 2002, and December 31, 2015, using retrospectively collected electronic databases.

104 Retrospectively collected exposure data introduces the p

105 M images, and sagittal breast MR images were retrospectively collected from 68 women who underwent br

106 A cohort of 26 370 subjects was retrospectively collected from a radiology archive of CT

107 aphic, and angiographic characteristics were retrospectively collected in 204 patients undergoing TAV

108 FA and household pesticide product use were retrospectively collected in telephone interviews from 2

109 An additional 55 retrospectively collected, frozen specimens were include

110 35 family members carrying this variant were retrospectively collected.

111 rict from January 1998 to December 2012 were retrospectively collected.

112 rom October 11, 2011, to June 30, 2016, were retrospectively collected.

113 Purpose To retrospectively compare the perfusion parameters of adva

114 We retrospectively compared 2 groups of patients who consec

115 We retrospectively compared renal outcomes in patients who

116 We retrospectively compared the outcomes of 954 patients tr

117 We then retrospectively compared the patients in this study with

118 C) from a transatlantic ARVD/C registry were retrospectively compared to assess structural disease pr

119 Of 94 patients with retrospectively confirmed brain metastases and at least

120 However, when ordinal judgment was used to retrospectively decode memory representations of absolut

121 Purpose To retrospectively define the strength of association betwe

122 he need for standardization of CMR timing to retrospectively delineate MaR and quantify myocardial sa

123 cutive patients post radiofrequency AFCA, we retrospectively derived a novel score for VLRAF predicti

124 ent of a CTG and regenerative treatment were retrospectively derived at three clinical centers.

125 Purpose To retrospectively determine if a modified clinical magneti

126 We retrospectively determined the pretransplant BKV neutral

127 The cohort was split into 4 groups: 74 were retrospectively diagnosed with both sarcopenia and osteo

128 To address this, we retrospectively documented the effect of API in patients

129 220 consecutive patients with melanoma were retrospectively enrolled between January 2009 and Decemb

130 ions between October 2011 and July 2013 were retrospectively enrolled.

131 Patients and Methods We retrospectively evaluated 4,903 patients from 128 Vetera

132 Patients and Methods We retrospectively evaluated 709 adult patients with Hodgki

133 The authors retrospectively evaluated 76 consecutive patients with P

134 (68)Ga-pentixafor PET/CT results were retrospectively evaluated against a histologic, bacterio

135 We retrospectively evaluated medical records and imaging st

136 pective non-Hodgkin lymphoma research study, retrospectively evaluated outcomes in patients with refr

137 We retrospectively evaluated the safety and efficacy of paz

138 the OptumInsight Clinformatics DataMart, we retrospectively evaluated the underlying factors behind

139 We retrospectively evaluated the utility of (68)Ga-PSMA-11

140 Two radiologists retrospectively evaluated US images on the basis of the

141 injection) (68)Ga-PSMA-11 PET/CT scans were retrospectively evaluated.

142 enter between June 2013 and August 2014 were retrospectively evaluated.

143 treal FNAB at an ocular oncology center were retrospectively evaluated.

144 with a minimum follow-up of 12 months, were retrospectively evaluated.

145 After retrospectively evaluating the clinical outcome of 500 c

146 ad a positive oral food challenge (OFC) were retrospectively examined at two major hospitals over a t

147 Materials and Methods The authors retrospectively examined the relationship between metabo

148 Patients misdiagnosed as having GBS were retrospectively excluded from the study.

149 rom March to September 2014, structured data retrospectively extracted from electronic health records

150 Lyme diagnosis was retrospectively extracted from the patient's medical rec

151 ired over multiple time points were examined retrospectively for 65 thyroid cancer patients, referred

152 nty FRALLE2000T-treated patients were tested retrospectively for NOTCH1/FBXW7/RAS and PTEN alteration

153 from 523 men with BM from GCT were collected retrospectively from 46 centers in 13 countries by using

154 Data were collected retrospectively from a prospective registry.

155 comes occurring within 1 year were collected retrospectively from chart review.

156 Data were collected retrospectively from individuals who collectively had 39

157 tation causing Best disease were ascertained retrospectively from the clinical and genetic databases.

158 Follow-up data were gathered retrospectively from the medical records of patients who

159 women eligible for analysis were identified retrospectively (from Jan 1, 2012, to Dec 31, 2014; 348

160 Nineteen patients retrospectively fulfilled common criteria of TCM, 79 pat

161 We retrospectively identified 10 patients who underwent cli

162 The authors retrospectively identified 118 patients who presented to

163 The authors retrospectively identified 195 patients with stage III N

164 We retrospectively identified 59 renal transplant recipient

165 Thereafter, we retrospectively identified 69 patients who had been succ

166 METHODS AND We retrospectively identified 96 patients with a reduced LV

167 ients with neurofibromatosis type 2 who were retrospectively identified as having a solitary tumor be

168 rials and Methods Ten patients with GBM were retrospectively identified by using routinely collected,

169 f hvKP were present in our U.S. hospital, we retrospectively identified four cases of CR-KP NSSTI dia

170 ndependent cohorts (41 and 79 patients) were retrospectively identified from the Comprehensive Longit

171 al of 752 patients diagnosed with PCNSL were retrospectively identified from the databases of 3 Frenc

172 ocal therapy and (18)F-FET PET scanning were retrospectively identified in 2 centers.

173 ocal therapy and (18)F-FET PET scanning were retrospectively identified in 2 centers.

174 Materials and Methods Retrospectively identified were 149 patients sampled per

175 ary 1, 2000, through December 31, 2014, were retrospectively identified.

176 without vascular invasion or metastasis was retrospectively identified.

177 RadLex(R) Playbook identifiers (RPIDs) were retrospectively identified.

178 ths after definitive surgical treatment were retrospectively identified.

179 using data from patients' hospital stays to retrospectively identify patient subgroups from a large,

180 The presence of RPD/SDD was confirmed retrospectively in 48 of 52 cases once the overall gradi

181 eaction (RT-PCR)-confirmed EVD were enrolled retrospectively in 5 Ebola treatment units in Liberia an

182 nd preoperative CBC parameters were obtained retrospectively in 654 EOC patients underwent primary su

183 Decision making was evaluated retrospectively in 76 patients with severe generalized j

184 y, and nonrelapse mortality was investigated retrospectively in a cohort of 492 patients undergoing a

185 ers of microcephaly cases were also observed retrospectively in French Polynesia in 2014.

186 Material/The study was carried out retrospectively in patients who were referred to the Ins

187 African adults with pneumonia were evaluated retrospectively in the UAD assay.

188 0 Helicobacter pylori infected patients were retrospectively included (female 57.5%; average age: 53.

189 ockholm and Helsinki CT scoring systems were retrospectively included from prospectively collected da

190 Consecutive scans were retrospectively included from time frames during which t

191 gadobutrol (0.1 mmol/kg of body weight) were retrospectively included in this regional ethics committ

192 om 18 hospitals or institutional centres and retrospectively included laboratory-confirmed pneumococc

193 c Q fever who were diagnosed since 2007 were retrospectively included until March 2015, when at least

194 ne computed tomographic (CT) angiograms were retrospectively included.

195 nance imaging prior to ICD implantation were retrospectively included.

196 ing ERC at our tertiary referral center were retrospectively included.

197 the role of interim PET scanning in HL, were retrospectively included.

198 utcome valence (prediction hypothesis) or by retrospectively interpreting the outcome (postdiction hy

199 hermore, full-scan high-resolution data were retrospectively interrogated versus a list of more than

200 We, retrospectively, marked HFOs, divided into fast ripples

201 Our primary analysis retrospectively matched cases and controls by age, sex,

202 methods, where data sets can be archived and retrospectively mined as new environmental contaminants

203 Based on this assay, we retrospectively observed, in eight cohorts enrolling 190

204 Medicare data were retrospectively obtained for participating ACOs from 201

205 p sequencing for BTK and PLCG2 was performed retrospectively on patients who experienced relapse and

206 l modeling, and this approach can be applied retrospectively or when assumptions for traditional anal

207 Experienced members of the surgical team retrospectively performed imaging assessments.

208 ariation in fidelity of value representation retrospectively predicted performance on the reinforceme

209 ve opioid use (binary exposure variable) was retrospectively queried from the home medication list of

210 We retrospectively queried the deidentified database of pat

211 (RAI-C), using a clinical questionnaire, or retrospectively (RAI-A), using variables from the surgic

212 Three radiologists retrospectively re-examined 97 consecutive patients with

213 Twenty-seven participants were retrospectively recruited: AR (n = 7), AS (n = 10) and c

214 were considered positive and were evaluated retrospectively regarding rejection episodes.

215 g (n = 4) of (225)Ac-PSMA-617 were evaluated retrospectively regarding toxicity and treatment respons

216 TRIAL REGISTRATION NUMBER: ISRCTN60143265 , retrospectively registered on the 24th of April 2017.

217 This study is "retrospectively registered".

218 Retrospectively registered.

219 ISRCTN33002849 , 2016/01/19, retrospectively registered.

220 We retrospectively report our clinical observations using 4

221 We retrospectively report our experience with (177)Lu-PSMA-

222 METHOD: Two hundred women recruited for retrospectively reported premenstrual emotional symptoms

223 Retrospectively review consecutive patients with fGGOs b

224 We retrospectively reviewed 119 patients receiving Pneumocy

225 We retrospectively reviewed 272 patients who underwent surg

226 METHODS AND We retrospectively reviewed 341 consecutive adults who unde

227 Material/We retrospectively reviewed 69 paediatric MRI sedations per

228 The authors retrospectively reviewed abdominal CT scans in 38 patien

229 xperienced radiologist, masked to histology, retrospectively reviewed all fused SPECT/MR images and s

230 y patients with 2 rare genetic variants were retrospectively reviewed and compared with a group of pa

231 METHODS AND We retrospectively reviewed and recorded social workers' cl

232 D ultrasound examinations were performed and retrospectively reviewed by 2 board-certified radiologis

233 age, 39 years; age range, 15-59 years) were retrospectively reviewed by two radiologists.

234 ere not blinded to histopathologic findings, retrospectively reviewed cancers missed at MP MR imaging

235 METHODS AND We retrospectively reviewed cardiac investigations and clin

236 We retrospectively reviewed clinical and intraoperative dat

237 Methods We retrospectively reviewed clinical histories of patients

238 Microbiology database records were retrospectively reviewed for all patients with endophtha

239 ophthalmic evaluation at ELWA Hospital were retrospectively reviewed for demographic information, le

240 Our institutional database (2007-2017) was retrospectively reviewed for patients with pathologicall

241 We retrospectively reviewed HCT recipients with HCoV detect

242 We retrospectively reviewed medical records of 740 patients

243 We retrospectively reviewed operative characteristics, intr

244 We retrospectively reviewed patients diagnosed with ATTRwt

245 We retrospectively reviewed patients with NLPHL diagnosed b

246 We retrospectively reviewed records of patients evaluated f

247 diagnostic accuracies for each approach, we retrospectively reviewed screening test performance in 1

248 We retrospectively reviewed the Determine TB-LAM lateral fl

249 We retrospectively reviewed the posttransplant outcomes of

250 ss the response to antiepileptic therapy, we retrospectively reviewed the treatment regimen and the c

251 le and 31 penicillin-resistant strains, were retrospectively reviewed to evaluate the clinical signif

252 Ga-PSMA PET/CT in 100 patients with BCR were retrospectively reviewed, and changes in plans were reco

253 t our institution between 1992 and 2009 were retrospectively reviewed.

254 Twenty-five patients with PANDO were retrospectively reviewed.

255 resonance (MR)-DWI and MR-defecography were retrospectively reviewed.

256 tilide reloading for atrial arrhythmias were retrospectively reviewed.

257 firmed with surgically pathologic proof were retrospectively reviewed.

258 gle surgeon from June 2012 to June 2015 were retrospectively reviewed.

259 confirmed by immunoblot) was performed were retrospectively reviewed.

260 traumatic canalicular laceration repair were retrospectively reviewed.

261 al and laboratory diagnosis of FFI have been retrospectively reviewed.

262 derwent LSV for stage 4A, 4B, and 5 ROP were retrospectively reviewed.

263 We retrospectively scored changes in management based on ea

264 We have retrospectively screened 2183 consecutive cases of PID i

265 We retrospectively screened 660 CIEDI cases from 2005 to 20

266 ed on a Q-Exactive Orbitrap were compared by retrospectively screening surface water samples for 95 p

267 In this Review, we retrospectively searched oncology drugs that were class

268 Between January 1999 and March 2015, we retrospectively selected all consecutive patients who un

269 quentially, spatiotemporally registered, and retrospectively selected by using an entropy-based appro

270 mean age, 58 years; range, 24-89 years) were retrospectively selected who were studied with cardiac M

271 ples from 16 immunocompromised patients were retrospectively selected.

272 FKBP5 gene have been shown to interact with retrospectively self-reported early life stress (ELS) in

273 We retrospectively sequenced the genomes of 194 P. falcipar

274 of biosensors, targeting the brain and liver retrospectively showed no significant difference in luci

275 We retrospectively simulated the stepwise reduction of (18)

276 We retrospectively studied 1199 paediatric donor-recipient

277 We retrospectively studied all women who delivered infants

278 We retrospectively studied the prognostic impact of DEL and

279 We retrospectively studied vancomycin taper and pulse treat

280 tive patients with Malattia Leventinese were retrospectively studied.

281 Baseline isolates were retrospectively tested for isoniazid monoresistance.

282 with successful GRE-based examinations were retrospectively tested for statistical equivalence by us

283 x1 or stx2 results were reported for frozen, retrospectively tested specimens.

284 We retrospectively tested weekly plasma samples from alloge

285 ect vancomycin in renal tissue and confirmed retrospectively that deleterious vancomycin-associated c

286 The purpose of this study was to analyze retrospectively the efficacy of TACE and its impact on O

287 (proximal, intermediate, distal) and applied retrospectively to NTP's research on hexavalent chromium

288 in reaction JCPyV was used prospectively and retrospectively to track the viral load within the patie

289 Tumor HA levels were measured retrospectively using a novel affinity histochemistry as

290 Model performance was evaluated retrospectively using an independent testing set.

291 ts becoming HIV infected to results obtained retrospectively using enzyme immunoassay and nucleic aci

292 ction, ability to approach prospectively and retrospectively, utility for hypothesis generation in ad

293 Purpose To retrospectively validate a first-pass analysis (FPA) tec

294 Conclusion The FPA technique was retrospectively validated in a swine model and has the p

295 The FPA technique was retrospectively validated in six swine (mean weight, 37.

296 We recruited women retrospectively (via medical record review) and prospect

297 Retrospectively, we recruited consecutive HL patients tr

298 n overlooked at imaging, and often diagnosed retrospectively when it is detected incidentally at the

299 We then evaluated the forecast retrospectively with available epidemiological informati

300 Prospective measurements were correlated retrospectively with standardized primary trial data.